Beruflich Dokumente
Kultur Dokumente
PII: S0378-8741(15)30132-X
DOI: http://dx.doi.org/10.1016/j.jep.2015.09.007
Reference: JEP9730
To appear in: Journal of Ethnopharmacology
Received date: 19 May 2015
Revised date: 4 September 2015
Accepted date: 6 September 2015
Cite this article as: Martina utovsk, Peter Capek, Ivana Kazimierov, Lenka
Pappov, Marta Jokov, Mria Matulov, Soa Fraov, Izabela Pawlaczyk and
Roman Gancarz, Echinacea complex chemical view and anti-asthmatic profile,
Journal of Ethnopharmacology, http://dx.doi.org/10.1016/j.jep.2015.09.007
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
Echinacea complex chemical view and anti-asthmatic profile
Martina utovska, Peter Capekb*, Ivana Kazimierova, Lenka Pappova, Marta Jokova,
a
Department of Pharmacology, Jessenius Faculty of Medicine Comenius University,
Martin's Biomedical Center (BioMed) Mal Hora 11161 4C, Martin, Slovakia
b
Institute of Chemistry, Center for Glycomics, Slovak Academy of Sciences, Dbravsk
Poland
ABSTRACT
Ethnopharmacological relevance
Echinacea purpurea (L.) Moench is one of the mostly used herbs in the traditional
medicine for the treatment of respiratory diseases. Modern interest in Echinacea is directed
to its immunomodulatory activity. Recent studies have shown that secretion of asthma-
related cytokines in the bronchial epithelial cells can be reversed by Echinacea preparations.
been isolated from its flowers by alkaline extraction and has been tested using an animal
1
The structural features of Echinacea purpurea complex was determined using chemical and
exposure of guinea pigs to ovalbumin. Echinacea complex was then administered 14 days in
50 mg/kg b.w. daily dose perorally. Bronchodilatory effect was verified as decrease in the
specific airway resistance (sRaw) in vivo and by reduced contraction amplitude (mN) of
histamine in vitro. The impact on mucociliary clearance evaluated measurement of ciliary beat
complex was verified by changes in exhaled NO levels and by Bio-Plex assay of Th2
cytokine concentrations (IL-4, IL-5, IL-13 and TNF-alpha) in serum and bronchoalveolar
Results
arabinogalactan moieties in Echinacea complex. The significant decrease in sRaw values and
smooth muscle that were similar to effects of control drug salbutamol confirmed Echinacea
complex bronchodilatory activity. The anti-inflammatory effect was comparable with that of
control agent budesonide and was verified as significantly reduced exhaled NO levels and
concentration of Th2 cytokines in serum and BALF. The values of CBF were changed only
Conclusion
inflammatory effects of Echinacea complex that was similar to effects of classic synthetic
2
drugs. Thus, results provide a scientific basis for the application of this herb in traditional
____________________
1. Introduction
plant. Several Echinacea species have been used in the traditional medicine to treat
infections, cold, cough, bronchitis, inflammations, etc. (Barrett, 2003; Goel et al. 2004;
Wagner et al. 1999). Echinacea is one of the most used plants in herbal medicine and in
species are still the subject of chemical and pharmacological research in order to identify
their active ingredients, however, the description of all constituents is still not completed.
A great deal of clinical trials was performed to verify the efficacy of Echinacea
describe their active principles. Four main groups of constituents are considered to be
3
stimulating, anti-inflammatory and anticoagulant activities (Pawlaczyk et al. 2009; Spelma
et al. 2009).
Echinacea polysaccharides, i.e. enhancing production of TNF-, IL-6 , IL-10, and IL-1-,
oxygen intermediates, etc. (Roesler et al. 1991; Steinmuller et al. 1993; Currier and Miller,
2000; Currier et al. 2002; Fonseca et al. 2014). Furthermore, it was found that active
polysaccharides did not stimulate B cells. Allergic asthma is a chronic obstructive disease
2011). Many herbs have shown interesting results in various target specific biological
treatment of asthma (Mali and Dhake, 2011). Recent studies have shown, that expression
of asthma-related cytokine genes and product secretions in the bronchial epithelial cells
asthma. This model can mimic the pathological symptoms common in humans suffered
from allergic bronchial asthma, for example airway hyperreactivity and inflammatory
4
2.1. Plant material and chemicals
Air-dried flowers of medicinal plant E. purpurea (L.) Moench were purchased from
a local market in Wroclaw, Poland. The identity of the plant was certified by Prof. K. D.
Kromer and J. Kochanowska from Botanical Garden of Wrocaw University, Poland and a
voucher specimen (No. 011493) has been deposited in the Botanical Garden of Wrocaw
University, Poland.
hydroxide, budesonide and chicken ovalbumine purchased from Sigma Aldrich (Lambda Life,
0.9 % saline.
procedure (Pawlaczyk et al., 2009). Shortly, flowering parts were minced and suspended
in 0.1 M sodium hydroxide at room temperature for 24 h and refluxed for 6 h. The rest of
concentrated to a lower volume and gradually extracted with hexane (1:1, v/v), diethyl
ether (1:1, v/v), chloroform (1:1, v/v), and chloroform and ethanol mixture (3:2, v/v).
Organic extracts were discarded while the water fraction was evaporated to a paste and
treated with methanol at room temperature. The soluble methanolic part was filtered off
and the dark residue was solubilized in deionized water, dialyzed and freeze-dried to give
5
2.3. General methods
temperature not exceeding 40 C. The content of carbohydrate, phenolic and protein was
(Dubois et al. 1956; Lowry et al. 1951; Singleton et al. 1999) and the uronic acid content
Sample was hydrolysed with 2 M TFA for 1 h at 120 C and the quantitative determination
of the neutral sugars was carried out in the form of their alditol acetates (Englyst and
(Thermo Scientific, USA) equipped with a Restek RT- 2330-NB column (0.32 mm 105
min at 250 C)265 C (20 C /min, 10 min at 265 C) and the flow rate of helium was 1
mL/min. Molecular mass determination of a sample was performed with HPLC Shimadzu
vis detector SPD-10AV using the column HEMA-BIO 1000 (8 mm250 mm) of particle
size 10 m (Tessek, Prague, Czech Republic). As a mobile phase 0.02 M phosphate buffer
pH 7.2 containing 0.1 M NaCl was used at a flow rate 0.8 mL/min. A set of dextran
standards was used for of the column (Gearing Scientific, Polymer Lab., Hertfordshire,
UK). The colorimetric assays were measured using UVVIS 1800 spectrophotometer
Magna 750 spectrometer with DTGS detector and OMNIC 3.2 software, where 128 scans
were recorded with 4 cm1 resolution. NMR spectra of conjugate were recorded in D2O at
60 C on Varian 400 NMR spectrometer on direct 5 mm PFG AutoX probe. Sample was
6
twice freeze-dried from D2O before measurements. For 1H and 13C NMR spectra,
chemical shifts were referenced to internal standard acetone ( 2.22 and 31.07,
respectively). For the assignment of signals one-dimensional (1H NMR) and two-
2.3. Animals
All experiments were approved by Institutional Ethics Committee of the Jessenius Faculty
Board/Institutional Ethic Board Office (IRB 00005636), complied with Slovakian and
European Community regulations for the use of laboratory animals and follow the criteria of
Adult male Trik strain guinea pigs (200-350 g) were obtained from approved breeding
(Dobra Voda, Slovakia) and were housed in approved animal holding facility for one-week
adapting period and subsequent several days adaptation to experimental conditions. The
animals were divided into the five groups, each consisting of 10 animals: Negative controls
(1) Healthy group and (2) Group of ovalbumin-sensitized animals (OVA+) received saline
(sodium chloride 0.9 %) per orally (p.o.); (3) Positive controls sensitized guinea pigs
received salbutamol (10 mg/kg b.w.) intraperitoneally (i.p.) once daily long-term (Sal LT) or
(4) received budesonide (3 mg/mL) by inhalation for 5 min to 14 days, respectively (Bud LT);
(5) Experimental group sensitized animals underwent long-term therapy with Echinacea
complex (50 mg/kg b.w.) per orally (p.o.), long-term (Ep LT). The doses of control drugs and
tested complex from medicinal plant E. purpurea were selected according to literature data
7
and results of our previous experiments (Whelan et al., 1993; Prisenkov et al., 2005;
reactivity changes on immunological basis, was performed during 21 days (Franova et al.
subcutaneously (1st day of sensitization) and intraperitoneally (3rd day). Further, 1-2 min
lasted inhalations of allergen was performed at 9th, 12th, 15th, 18th and 20th days using
bodyplethysmograph for small laboratory animals (HSE type 855, Hugo Sachs Elektronik,
Germany). Allergic inflammation was confirmed as skin reaction increase in exhaled nitric
Twenty four hours after the last administration of allergen animals have been treated by
saline, control drugs and Ep isolate for a period of 14 days. Budesonide and salbutamol
were used as the anti-inflammatory and bronchodilatory controls, respectively. After these
treatments, animals have been used for evaluation of the Echinacea effect on defence
reflexes of airways and its ability to suppress allergic inflammation process by different in
calculated by Pennock et al. (1979) and their changes were regarded as indicator of in vivo
8
airways reactivity. The sRaw is proportional to phase difference between nasal and
thoracic respiratory airflow. The changes in sRaw were measured under the basal
conditions and then during 1 min consecutively after the short (30 s) exposure to
contractile mediators: citric acid (0.3 M), histamine and methacholine (both 10-6 M).
Between the bronchoprovoking agent exposure and measurement of sRaw was an interval
1 min, during which fresh air was insufflate into the nasal chamber. The effect of
(acetylcholine and histamine) were tested by organ tissue bath method (Sutovska et al.
2012). Briefly, guinea pigs were killed by transversal interruption of neck spinal cord.
Consequently the respiratory organs were removed. Four strips (two of tracheal and two of
pulmonary smooth muscle) obtained from each animal were placed into organ bath
CO2), held at the temperature 36 0.5 C, maintained at pH 7.5 0.1. Single strips were
fixed onto the sliding arm and the other end was bound with a thin thread to a hook of a
transducer (Experimetria Ltd., Hungary). The tension was used to monitor the intensity of
9
The changes in exhaled nitrogen oxide (eNO) values were used as rough indicator of
airway inflammation and anti-inflammatory effect (Sutovska et al. 2013). Animals were
placed into the offline chamber sampling connected with NIOX Flex Offline Start Kit 04-
1210-F (Aerocrine AB, Sweden), breathed NO free air for 5 min. Subsequently the
exhaled gas (flow rate 5 mL/s) was analysed during 7 s. NIOX uses the high sensitivity
billion, ppb).
The experiments were carried out under the standard laboratory conditions (temperature
2124 C and humidity at 55 10 %). The temperature of the microscopic glass slide and
the saline used as a nutritive medium for cilia, were kept in the range of 3738 C.
Following transversal interruption of the male guinea pigs neck spinal cord, transverse
access to the trachea was made approximately in the middle of its normal length. Ciliated
samples were obtained by cytology brush, which was dipped into the saline and then
gently rotated on the mucosal surface of the animal trachea. Tracheal brushings were
immediately placed into saline solution and were processed to microscopic preparation.
Microscopic preparations were examined 3 minutes after brushing the tracheal cilia
using phase contrast inverted biological microscope (Kvant model IM1C, Slovakia).
Beating ciliated cells were recorded using a digital high speed video camera (Basler
A504kc; Basler AG, Germany) on frame rate from 256 to 512 fps (frames per second).
There were approximately 10-12 video records of the same microscopic preparation
performed at 1 minute intervals and duration of each record was approximately 5-10
10
seconds. Video records were analysed using LabVIEW Software to generate a ciliary
region of interest (ROI), intensity variation in selected ROI and intensity variance curve.
Curve was then analysed according to Hargas et al. (2011) method using fast Fourier
transform algorithm (FFT). Fourier spectrum of each intensity variance curve was then
equal to frequency spectrum of cilia beating in each ROI. The median of frequency (Hz)
for each ROI and their arithmetic means referred to definite CBF value for each
microscopic preparation.
The blood from guinea pigs heart was collected immediately after transversal spinal
lavage was performed with warm saline (37 C) in volume calculated according body
weight of animal (10 mL/kg). Saline was injected and withdrawal via the cannula placed
into the right bronchus. Serum and supernatant from biological fluids were obtained by
centrifugation blood at the centrifugal force 2054 g for 5 min and bronchoalveolar
The apparatus Bio-Plex 200 System and TH1/TH2 panel Human Cytokine (Bio-Rad,
USA) were used for cytokine levels assessment. The assay was designed on magnetic
coupled beads were first incubated with antigen standards, samples, or controls followed
by incubation with biotinylated detection antibodies. After washing away the unbound
phycoerythrin (S-P) conjugate. Following the removal of S-P excess, the beads were
passed through the Bio-Plex 200 suspension array reader equipped with two lasers, one
11
(532 nm excitation) for analytes quantification and second (635 nm excitation) for
cytokine identification in small volume samples, which measures the fluorescence of the
beads and of the bound S-P. All washes were performed using a Bio-Plex Pro wash station.
High-speed digital processor manages data output and Bio-Plex Manager 6.0 software
2.9. Statistics
All obtained data were evaluated with one-way analysis of variance (ANOVA) with the post
hoc Bonferroni test using GraphPad Prism 6 software. Data are presented as mean standard
error of the mean (SEM). The results with p<0.05 was considered as statistically significant.
Significances of p<0.05, p<0.01 and p<0.001 are shown by one, two and three symbols ( vs
multi-step extractions with organic solvents, dialysis and freeze-drying afforded a dark
brown Echinacea complex in 1.8% yield on dry plant. HPLC and GPC analyses showed
one single peak of molecule mass at around 10 kDa indicating thus its molecular
(14%) and uronic acids (11.2 %). Analysis of the carbohydrate part showed the presence
12
of uronic acids (30%), galactose (Gal, 22%), arabinose (Ara, 17%) and rhamnose residues
(Rha, 13%), while other sugars were found in lower contents, i.e. xylose (Xyl, 9%),
glucose (Glc, 6%), mannose (Man, 2%) and fucose (Fuc, 1%). The FTIR analysis
carbohydrates and phenolics as the dominant constituents, while proteins were found in a
In the 1H NMR spectrum of Echinacea complex (Fig. 1), three regions of signals
could be distinguished. Signals in the region at 96 reveal the presence of aromatic rings
in phenolic compounds; carbohydrate signals were present mainly in the region at 5.53,
while those due CH2, CH3 signals of deoxy sugars, proteins, phenolics and acetyl groups
were located in the region at 30.6. Broad signals reflect high molecular mass of the
conjugate. Dominant sugar components, particularly galacturonic acid (GalA), Gal, Ara
and Rha, have been identified by sugar analysis. Consequently, they afforded dominant
were used for identification of sugars, their linkage types as well as types of carbohydrate
polymers present in Echinacea complex. In the -anomeric region the most important
signals in form of singlets were due to Araf at 5.21/110.25 and 5.04/108.62. All other
signals were of low intensity and very broad. The most intensive overlapped -anomeric
H1/C1 cross peaks at characteristic chemical shifts at 4.48/104.34 and 4.44/104.10 have
been identified as 1,3,6--Gal and 1,6-linked Gal. The presence of 6-linked Gal units
was evident from H6/C6 cross peaks with characteristic chemical shifts at 4.01,
3.88/70.61. These data are in a very good agreement with data published for
arabinogalactan type II isolated from C. arabica (Capek et al. 2010) with a highly
branched 1,3--galactan backbone with short 1,6-linked Gal side chains, which were also
13
branched at O3 by Gal and Araf. The 1,3-linked Gal signals were not found.
Characteristic chemical shifts of Araf units confirmed two types of linkages: one as Gal
downfield shift of Araf C5 signal due to 1,5-linkage was confirmed by H5/C5 cross
peaks at 3.885, 3.795/67.84. These facts indicate that one component in the Echinacea
with C6 chemical shift 17.56 gave a clear evidence about Rhap presence. It can form a
branching element in arabinogalactans (Nunes et al. 2008), but due to a high content of
It was found that HSQC contains also signals of two O-methyl groups at H/C
3.45/58.60 and 3.45/60.78. For their location identification the comparison of cross peaks
chemical shifts in the HSQC spectrum of Echinacea complex with published NMR data of
not substituted, acetylated and O-methylated 1,4-linked galacturonans was used for
analysis. Chemical shift of OMe group at C6 in GalA ester was identified at 3.80/54.1
and H5/C5 at 5.13/72.0 (Popov et al. 2011). Based on OMe chemical shifts and missing
signal at H5/C5 at 5.13/72.0 a conclusion was made that GalA in Echinacea complex is
not C6 esterified by OMe. Further analysis has shown that OMe H/C chemical shifts
values are in agreement with data published for substituted 1,6-linked -galactan at C3 by
OMe isolated from Salvia officinalis L. (Capek, 2008). Thus the location of OMe on Gal
units is highly probable. The presence of acetyl groups in NMR spectra was reveal by CH3
signals of OAc cross peaks at H/C 2.020/23.527, 2.060/21.28 and 2.158/21.28 and
group. Together with cross peaks due to CH2 at 2.009/28.49, 2.226/34.28 and CH3
14
groups at 0.857/15.84, 0.867/18.69 and 0.846/22.78 they are the most important signals
due to proteic part of the complex. All other signals are too broad and of low intensity to
NMR data suggest the presence of complex mixture of arabinogalactan type II and
components. Chemical shifts of Araf units do not indicate the presence of arabinans, but
galactans cant be excluded. Polyphenolics show large signals in 1H NMR spectrum which
3.2. The influence of Echinacea and control drugs on defence reflexes of the airways
leads to complex of changes that almost mimic the asthma phenotype in human, e.g.
typical histological features and changes in cytokines and mediators production (Franova
resistance values and sRaw induced by citric acid (AC), histamine and methacholine (Fig.
involved in AHR. The significant increase in basal hyperreactivity and in the response on
contracting mediators is the common feature in asthma and it was confirmed in sensitized,
15
p<0.001; methacholine, p<0.01). Furthermore, Echinacea complex significantly reduced
basal hyperreactivity (p<0.001) and its effect was similar to that of salbutamol, a standard
paediatric pulmonologists and important therapeutic decisions are based on this approach.
According to Mahut et al. (2009) sRaw is very sensitive parameter appropriate to detect
well as basal sRaw. These values characterized basal hyperreactivity. These findings
smooth muscles after treatment with acetylcholine and histamine, used as exogenous
contractile agents in cumulative concentrations. In the Figs. 4 and 5 the highest amplitudes
are observed in sensitized (OVA+) tissues, while the lowest ones are in tissues of animals
long term treated by Echinacea complex. Moreover, amplitudes are even significantly
lower than those due to salbutamol treated animals, especially at low concentration of
histamine (10-6 M) added directly into the pulmonary muscle strips or at high
concentration of histamine (10-4 and 10-3 M) in the case of tracheal smooth muscle. The
accepted, that asthma is a disease of small diameter intraparenchymal bronchi and thus a
good response of the lung tissue to Echinacea complex be regarded as a very positive
outcome.
16
The evaluation of a ciliary beat frequency (CBF) of healthy and treated animals is
shown in Fig. 6. Results showed that allergic inflammation induced by repetitive exposure
long-term treatment of animals with the Echinacea complex did not change the frequency
of cilia beating, that is, Echinacea complex has no effect on the natural cilia clearance.
The control drug budesonide, tested under the same condition, changed CBF only
targeted by various stimuli, e.g. serotonin or TNF- caused the increase in the frequency
of cilia beating (Weiterer et al. 2014) and IL-13 inhibits not only CBF but also alter the
morphology of the ciliated cells (Laoukili et al. 2001) . CBF is a key parameter of
mucociliary clearance and ciliary transport efficiency is linearly dependent on the CBF
(Braiman and Priel, 2001). Our study showed that both, budesonide and Echinacea do not
3.3. The influence of Echinacea and control drugs on allergic inflammation of airways
Two ways, i.e. indirect and direct were used to evaluate the influence of Echinacea
on allergic inflammation of airways. The indirect method of exhaled nitrogen oxide (eNO)
measurement is based on the fact, that the level of eNO is higher in animals with a
developed inflammation of airways. As can be seen from the Fig. 7, the levels of eNO
measured in animals long term treated by Echinacea complex was significantly lower
than that of sensitized (diseased) animals. It was found that levels of eNO in animals
treated by Echinacea complex were comparable with those of animals treated by classic
17
Indicative results of Echinacea complex on allergic inflammation of airways were
Human Cytokine allows us to evaluate changes in cytokines that are responsible for key
features of allergic asthma: IL-4, IL-5, IL-13 and TNF . Results showed that the
cytokine levels in both, BALF and plasma (Fig. 8). Furthermore, the induced decrease by
Echinacea complex was more significant than the budesonide, with the exception of
plasma levels of IL-5 and IL-13. The reduction in the BALF cytokines appears to be the
most important results with regard to allergic inflammation, as this shows that Echinacea
inflammation.
Echinacea complex. As reported earlier, significantly increased eNO was regularly found
in the developed allergic inflammation of the airways and eNO is normally reduced by
and showed a significant reduction in the levels of eNO in animals sensitized with
ovalbumin and treated long-term with Echinacea complex. Several studies have shown an
human subjects suffering from untreated asthma and have found correlations between
eNO and airway eosinophilia (Redington, 2006). Eosinophils, T cells and mast cells have
been shown not only as a source of iNOS, but also the mediators and cytokines, e.g., IL-4,
IL-5, IL-13 and TNF- by stimulated increased of iNOS expression in airway epithelial
18
cells (Benson et al., 2011; Paoliello-Paschoalato et al., 2005) and played a key role in
was supported also by the results of the Bio-Plex assay, which showed a significant
decrease in levels of key cytokines mediating asthma in plasma as well as in BALF. The
and Sharma et al. (2009). Authors studied profile of produced cytokines and chemokines
transfected cell lines. Reduced BALF levels of IL-4, IL-5, IL-13 and TNF- evidenced the
(Holgate, 2011).
4. Conclusion
pigs with experimentally induced allergic airway inflammation. Using animal model of
allergic asthma, Echinacea showed potency to suppress both, airway hyperreactivity and
19
disorders of the airways, such as asthma and thus provide a scientific basis for the
Acknowledgements
Studies were supported by the project BioMed co-financed from EC sources and by the
grants VEGA No. 1/0165/14 and 2/0018/15, MZ No. 2012/35-UKMA-12 and APVV
References
Altamirano-Dimas, M., Sharma, M., Hudson, JB., 2009. Echinacea and anti-inflammatory
cytokine responses: Results of a gene and protein array analysis. Pharm. Biol. 47, 500
508.
Barrett, B., 2003. Medicinal properties of Echinacea: A critical review. Phytomed. 10 (1),
66 86.
Benson, R.C., Hardy, K.A., Morris, C.R., 2011. Arginase and arginine dysregulation in
Blumenkrantz, N., Asboe-Hansen, O., 1973. New method for quantitative determination of
Braiman, A., Priel, Z., 2001. Intracellular stores maintain stable cytosolic Ca2+ gradients in
Capek, P., Matulova, M., Navarini, L., Suggi Liverani, F., 2010. Structural features of an
20
Carbohydr. Polym. 80, 180185.
from
Currier, N.L., Lejtenyi, D., Miller, S.C., 2002. The effect with time of administration in
Currier, N.L., Miller, S.C., 2000. Natural killer cells from aging mice treated with extracts
from Echinacea purpurea are quantitatively and functionally rejuvenated. Exp. Gerontol.
35, 627639.
Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., Smith, F., 1956. Colorimetric
method for determination of sugars and related substances. Anal. Biochem. 28 (3), 350
355.
Englyst, H.N., Cummings, J.H., 1984. Simplified method for the measurement of total non-
Feske, S., Skolnik, E.Y., Prakriya, M., 2012. Ion channels and transporters in lymphocyte
Fonseca, F.N., Papanicolaou, G., Lin, H., Lau, C.B.S., Kennelly, E.J., Cassileth, B.R.,
Franova, S., Joskova, M., Sadlonova, V., Pavelcikova, D., Mesarosova, L., Novakova, E.,
21
Sutovska, M., 2013. Experimental model of allergic asthma. Ad. Exp. Med. Biol. 756, 49-
55.
Goel, V., Lovlin, R., Barton, R., Lyon, M.R., Bauer, R., Lee, T.D.,Basu, T.K., 2004.
29, 7583.
Harga, L., Koniar, D., tofan, S., 2011. Sophisticated Biomedical Tissue Measurement
Holgate, S.T., 2011. The sentinel role of the airway epithelium in asthma pathogenesis.
Kocmalova, M., Oravec, M., Adamkov, M., Sadlonova, V., Kazimierova, I., Medvedova,
I.,
Joskova, M., Franova, S., Sutovska, M., 2015. Potassium ion channels and allergic
Laoukili, J., Perret, E., Willems, T., Minty, A., Parthoens, E., Houcine, O., Coste, A.,
Jorissen,
M., Marano, F., Caput, D., Tournier, F., 2001. IL-13 alters mucociliary differentiation
and ciliary beating of human respiratory epithelial cells. J. Clin. Invest. 108, 18171824.
Lowry, O., Rosebrough, N., Farr, L., Randall, R., 1951. Protein measurement with the
Mahut, B., Trinquart, L., Bokov, P., Le Bourgeois, M., Waernessyckle, S., Peiffer, C.,
Delclaux, C., 2009. Relationships between Specific Airway Resistance and Forced
22
Expiratory Flows in Asthmatic Children. Plos One, 4 (4), e5270. Doi:
10.1371/journal.pone.0005270.
Mali, R.G., Dhake, A.S., 2011. A review on herbal antiasthmatics. Orient. Pharm.
Nunes, F.M., Reis, F.M., Silva, V.A., Domingues, A.M.S., Coimbra, M.A., 2008.
Paoliello-Paschoalato, A.B., Oliveira, S.H., Cunha, F.Q., 2005. Interleukin 4 induces the
Pawlaczyk, I., Czerchawski, L., Pilecki, W., Lamer-Zarawska, E., Gancarz, R., 2009.
Pennock, B.E., Cox, C.P., Rogers, R.M., Cain, W.A.,Wells, J.H., 1979. A non-invasive
technique for measurement of changes in specific airway resistance. J. Appl. Physiol. 46,
399-406.
Percival, S.S., 2000. Use of echinacea in medicine. Biochem. Pharm. 60, 155-158.
Popov, S.V., Ovodova, R.G., Golovchenko, V.V., Popova, G.Y., Viatyasev, F.V., Shashkov,
polysaccharide isolated from sweet pepper using a simulated gastric medium. Food Chem.
124, 309315.
23
Prisenkov, L., Nosov, G., Hromdkov, Z., Ebringerov, A., 2011. The
asthma
Roesler, J., Steinmuller, C., Kiderlen, A., Emmendorffer, A., Wagner, H., Lohmann-
Matthes, M.L., 1991. Application of purified polysaccharides from cell cultures of the
plant Echinacea purpurea to mice mediates protection against systemic infections with
Sharma, M., Schoop, R., Hudson, J.B., 2009. Echinacea as an antiinflammatory agent: the
Singleton, V.L., Orthofer, R., Lamuela-Raventos, R.M., 1999. Analysis of total phenols
Spelman, K., Wetschler, M.H., Cech, N.B., 2009. Comparison of alkylamide yield in
ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-
Steinmuller, C., Roesler, J., Grottrup, E., Franke, G., Wagner, H., Lohmann-Matthes,
M.L., 1993. Polysaccharides isolated from plant cell cultures of Echinacea purpurea
Sutovska, M., Kocmalova, M., Joskova, M., Adamkov, M., Franova, S., 2015. The Effect
24
Epithelium in Guinea Pig Allergic Asthma Model. Gen. Physiol. Biophys. 34(2), 167-76.
Sutovska, M., Kocmalova, M., Adamkov, M., Vybohova, D., Mikolka, P., Mokra, D.,
Hatok,
J., Antosova, M., Franova, S. (2013). The long-term administration of Orai1 antagonist
utovsk, M., Capek, P., Fraov, S., Pawlaczyk, I., Gancarz, R., 2012. Antitussive and
utovsk, M., Capek, P., Komalov, M., Pawlaczyk, I., Zaczyska, E., Czarny, A.,
Uhliarikov, I., Gancarz, R., Fraov, S., 2014. Characterization and pharmacodynamic
Wagner, H., Kraus, S., Jurcic, K., 1999. Search for immunostimulating agents fromplants
and other natural sources, in: Wagner, H. (Ed.), Immunomodulatory Agents from Plants.
Weiterer, S., Schulte, D., Mller, S., Kohlen, T., Uhle, F., Weigand, M.A., Henrich, M.
2014. Tumor Necrosis Factor Alpha Induces a Serotonin Dependent Early Increase in
Ciliary Beat Frequency and Epithelial Transport Velocity in Murine Tracheae. Plos One,
Whelan, C.J., Johnson, M., Vardey, C.J., 1993. Comparison of the anti-inflammatory
properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br. J.
25
Figure legends
Fig. 3. The changes in specific airways resistance (sRaw) under the basal conditions and
changes in this parameter induced by short-time inhalation of citric acid (AC), histamine
(His) and methacholine (Met) measured in unsensitized (healthy) and sensitized vehicle-
treated animals (OVA+), and in groups of sensitized guinea pigs received long-term positive
control drug salbutamol (Sal LT) or E. purpurea complex (Ep LT). p < 0.05 and
p<
chamber. The tracheal reactivity of animals treated long-term by E. purpurea complex (Ep
LT) was compared to contractile response of control sensitized groups treated by vehicle
(OVA+) and salbutamol (Sal LT). *p < 0.05 and **p < 0.01 vs OVA+; +p < 0.05 vs
salbutamol.
Fig. 5. The changes in pulmonary smooth muscle (mN) contractile response on cumulative
long-term by Echinacea complex (Ep), vehicle (OVA+) and salbutamol (Sal). *p < 0.05;
**p < 0.01 and ***p < 0.001 vs OVA+; +p < 0.05 vs salbutamol.
26
Fig. 6. The changes in ciliary beat frequency (CBF) evaluated in unsensitized (healthy)
animals and following sensitized groups: Echinacea complex (Ep LT), negative control
(OVA+) and positive budenoside control (Bud LT) as the response on long-term
administration of Echinacea complex, vehicle and budesonide. p < 0.05 vs healthy animals.
guinea pigs, sensitized negative control group treated by vehicle (OVA+), experimental
group of animals treated long-term by Echinacea complex (Ep LT) and positive control
group received long-term budesonide (Bud LT). p < 0.01 vs healthy; *p < 0.01 vs OVA+.
Fig. 8. The comparison of changes in levels of cytokines IL-4, IL-5, IL-13 and TNF-
measured in BALF (part A) and plasma (part B) obtained from unsensitised (healthy) guinea
Echinacea complex (Ep LT) and budesonide (Bud LT).p<0.05, p<0.01 and p<0.001 vs
healthy animals; *p<0.05, **p<0.01 and ***p<0.001 vs OVA+; ++p<0.01 and +++p<0.001 vs
budesonide.
27
Abbreviations
Ep, Echinacea complex; sRaw, specific airway resistance; CBF, ciliary beat frequency; NO,
nitrogen oxide; BALF, bronchoalveolar lavage fluid; Th2 cytokine, T helper cell cytokine;
IL-1-, IL-4, IL-5, IL-6, IL-10, IL-13, interleukins 1, 4, 5, 6, 10, 13; TNF-, tumor necrosis
factor alpha; NMR, nuclear magnetic resonaces; AC, Citric acid; HCl, hydrochloric acid;
salbutamol long term; Bud LT, budenoside long term; Ep LT, Echinacea complex long term;
Al(OH)3, aluminium hydroxide; eNO, exhaled nitric oxide; ASM, airway smooth muscle;
ppb, particle per billion; ROI, region of interest; FFT, Fourier transform algorithm; GalA,
galacturonic acid; OMe, O-methyl; Gal, -linked galactose; Araf, arabinofuranose; AHR,
airway hyperreactivity; iNOS, inducible NO-synthase; Gal, galactose; Ara, arabinose; Rha,
rhamnose; Xyl, xylose; Glc, glucose; Man, mannose; Fuc, fucose; GalA, galacturonic acid;
28
Influence on airway
defense mechanisms
Ovalbumin
sensitized
Echinacea flowers
PPP complex
0.1 M NaOH
in vivo/in vitro
tests
PPP: polysaccharide-polyphenolic-protein
Influence on allergic
inflammation
Graphical abstract
29
Figure